Blocking a protein normally credited with suppressing leukemia may be a promising therapeutic strategy for an aggressive form of the disease called acute myeloid leukemia (AML), suggests new research in the iJournal of Clinical Investigation/i. Researchers from Cincinnati Children's Hospital Medical Center report their results in a study posted online Aug. 27 by the journal. The protein scientists targeted is a transcription factor known as RUNX1, ...
via Medindia Health News More READ
No comments:
Post a Comment